Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006578

SVP and General Counsel sold 2,813 shares at an average $56.51 ($158,959)

  • SVP and General Counsel acquired 2,813 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Taylor Stacy L SVP and General Counsel 2021-01-29 Option exercise +1,042 $7.80 $8,128 2,342 D: show line 1 in the form
Taylor Stacy L SVP and General Counsel 2021-01-29 Option exercise +1,771 $6.55 $11,600 4,113 D: show line 2 in the form
Taylor Stacy L SVP and General Counsel 2021-01-29 Sale −1,095 $55.71 $61,002 3,018 D: show line 3 in the form
Taylor Stacy L SVP and General Counsel 2021-01-29 Sale −1,090 $56.59 $61,683 1,928 D: show line 4 in the form
Taylor Stacy L SVP and General Counsel 2021-01-29 Sale −628 $57.76 $36,273 1,300 D: show line 5 in the form
Open-market sales · 2,813 sh · avg $56.51 · $158,959

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Taylor Stacy L SVP and General Counsel 2021-01-29 Option exercise · Stock Option (Right to Buy) −1,042 28,125 D: show line 6 in the form
Taylor Stacy L SVP and General Counsel 2021-01-29 Option exercise · Stock Option (Right to Buy) −1,771 24,792 D: show line 7 in the form
Loading xslF345X03/doc4.xml…